OTC - ACTIVE INGREDIENT SECTION
ACTIVE INGREDIENTS: OCTINOXATE 7.50% [] OCTISALATE 5.00% [] AVOBENZONE 3.00%
ACTIVE INGREDIENTS: OCTINOXATE 7.50% [] OCTISALATE 5.00% [] AVOBENZONE 3.00%
WARNING: KEEP OUT OF EYES. STOP USE IN IRRITATION OCCURS. KEEP OUT OF REACH OF CHILDREN.
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 68758-009-01 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d1-0c42-f424-e053-dadaa90a57ce | d0cbd790-c401-42a3-8a5b-9ecfb2f74bd4 |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 68758-009-01 | EXTEN-10INSTANT YOUTH BOOSTING MOISTURIZER SPF 15 | 1 in 1 CARTON | CREAM | 1 | 3 | |
| 68758-009-02 | EXTEN-10INSTANT YOUTH BOOSTING MOISTURIZER SPF 15 | 50 mL in 1 TUBE | CREAM | 50 | 3 |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| AVOBENZONE | ACTIVE INGREDIENT | G63QQF2NOX | 3 | |
| OCTINOXATE | ACTIVE INGREDIENT | 4Y5P7MUD51 | 3 | |
| OCTISALATE | ACTIVE INGREDIENT | 4X49Y0596W | 3 | |
| AVOBENZONE | ACTIVE MOIETY | G63QQF2NOX | 3 | |
| OCTINOXATE | ACTIVE MOIETY | 4Y5P7MUD51 | 3 | |
| OCTISALATE | ACTIVE MOIETY | 4X49Y0596W | 3 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 68758-009 | 68758-009-02, 68758-009-01 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| OCTINOXATE | 4Y5P7MUD51 | ACTIB |
| OCTISALATE | 4X49Y0596W | ACTIB |
| AVOBENZONE | G63QQF2NOX | ACTIB |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 24a1d522-1d6d-4ec2-a80e-971908135b34 | d0cbd790-c401-42a3-8a5b-9ecfb2f74bd4 | 2010-05-14 | Warnings | 24a1d522-1d6d-4ec2-a80e-971908135b34 d0cbd790-c401-42a3-8a5b-9ecfb2f74bd4 |
Adverse event summaries are temporarily unavailable. Other product information remains available.